Cogentus Pharmaceuticals Report issue

For profit Phase 3
Founded: Menlo Park CA United States (2006)
Status: Defunct (2009)

Organization Overview

First Clinical Trial
2007
NCT00620802
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 3)

Coronary Artery Disease (Phase 3)

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3